Gofen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gofen

What is Gofen?

Gofen is an oral medication containing ibuprofen as its active pharmaceutical ingredient. It belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). The medication is commonly formulated in clear liquid gel capsules, which are designed to facilitate faster absorption into the bloodstream compared to traditional solid tablets.

Mechanism of Action

The primary function of Gofen is to inhibit the activity of enzymes called cyclooxygenases (COX-1 and COX-2). These enzymes play a central role in the production of prostaglandins, which are lipid compounds in the body that signal pain and trigger inflammatory responses. By reducing the concentration of prostaglandins, Gofen helps to mitigate the sensation of pain and decrease swelling.

General Uses

Gofen is utilized to provide temporary relief from various types of mild to moderate discomfort. Its properties make it effective for addressing different physical symptoms, including:

  • Pain Management: It is used for headaches, dental pain, muscular aches, and backaches.
  • Fever Reduction: It acts as an antipyretic, helping to lower elevated body temperatures.
  • Inflammation Control: It helps reduce the localized swelling and tenderness associated with minor injuries or chronic conditions like menstrual cramps and certain types of joint discomfort.

Formulation Characteristics

The liquid-filled capsule technology used in Gofen is intended to provide a convenient delivery system. Once swallowed, the capsule shell dissolves, releasing the pre-solubilized ibuprofen. This allows the active ingredient to reach the site of pain or inflammation efficiently.

Regulatory References

  1. NIH Review

What side effects are possible with Gofen?

Possible side effects and safety information

Ibuprofen, the active ingredient in Gofen, is associated with a range of possible adverse reactions that are officially classified by frequency and the physiological system affected, according to government regulatory documentation.


Classification of Documented Adverse Reactions

Adverse effects are categorized by the body system involved. Gastrointestinal Disorders are commonly reported, including dyspepsia, nausea, and abdominal pain. Headache and dizziness are also common reactions classified under Nervous System Disorders.

Uncommon side effects may involve gastrointestinal ulceration or bleeding, hypersensitivity reactions (such as skin rash), or vomiting. Rare reactions include aseptic meningitis and renal papillary necrosis. Severe but very rare events include severe cutaneous reactions like Stevens-Johnson syndrome (SJS).


Serious Safety Considerations and Constraints

As an NSAID, the medication carries a documented risk of serious adverse reactions, which may occur without warning. These include severe gastrointestinal events (ulceration, bleeding, and perforation) and an increased risk of serious arterial thrombotic events, such as myocardial infarction and stroke.

Regulatory safety constraints specify that the risk of these serious cardiovascular and gastrointestinal events is higher with prolonged duration of use and at higher therapeutic doses.

Population-specific safety notes highlight that older adults face a higher risk of severe adverse reactions, particularly GI bleeding. The medicine is formally contraindicated in individuals with severe heart failure, severe renal failure, or active peptic ulceration, as defined in official prescribing information.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory documents define the overdose profile for Ibuprofen (the active ingredient in Gofen) by listing explicit systemic manifestations and severe, potentially fatal outcomes. Acute toxicity may present with gastrointestinal symptoms, including nausea, vomiting, and abdominal pain, alongside central nervous system effects such as drowsiness, dizziness, confusion, or severe headache.


Required Emergency Actions

Action Mandate Regulatory Guidance
Immediate Medical Help Regulators mandate to get medical help or contact a Poison Control Center right away in case of overdose, even if the person appears well.
Severe Complications Urgent help is required due to the risk of life-threatening outcomes, including acute renal failure, shock, coma, and potentially fatal gastrointestinal bleeding or perforation.

Supportive Management and Context

Treatment is entirely symptomatic and supportive, as no specific antidote is known for Ibuprofen overdose. Supportive measures described include administering activated charcoal and carrying out gastric lavage for decontamination, alongside monitoring of vital signs in a clinical setting. Regulatory labeling notes that the risk of severe gastrointestinal events is higher in elderly or debilitated patients.

Therapeutic Uses of Gofen

What Gofen Treats: Main Uses and Benefits


Gofen (Ibuprofen) is commonly applied for symptomatic relief in situations involving discomfort, fever, and inflammation. The medication is relevant in contexts where supportive symptom management is appropriate.

Easing Pain, Inflammation, and Fever

The medication is relevant for easing symptoms related to physical discomfort, addressing mild to moderate pain that may interfere with routine activities. This involves treating headaches, general body aches, dental pain, and the discomfort of menstrual cramps (primary dysmenorrhea). This symptomatic support is relevant for managing manifestations linked to inflammatory or irritative states, such as joint swelling and stiffness associated with chronic conditions like osteoarthritis and rheumatoid arthritis, or minor musculoskeletal injuries. Furthermore, Gofen is relevant in conditions characterized by systemic imbalance, and is applied to help with high temperature (fever), particularly when accompanied by aches during the common cold or influenza.

“It is commonly used to help patients cope more steadily with difficult episodes and supports general well-being during acute phases.”

This application offers symptomatic relief that may assist with maintaining a sense of functional stability and contributes to easing the overall symptom load.

Quick Fact: Relief for Pain, Fever, and Inflammation Gofen is commonly used for managing symptoms associated with recurrent or episodic manifestations, applied in scenarios where additional management of discomfort is required, and helps address symptoms that create noticeable physiological strain.

Regulatory References

  1. NIH National Library of Medicine overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Gofen?

The official eligibility profile for Gofen (Ibuprofen) is determined by governmental regulatory authorities (such as the FDA and EMA) and defines specific populations for permitted use, restricted use, and absolute contraindication.

Absolute Contraindications

Use of Gofen is strictly contraindicated for several populations as documented in regulatory labeling. Individuals who must not use this medicine include those with a known hypersensitivity to Ibuprofen or other NSAIDs (such as aspirin) that results in asthma, angioedema, or urticaria. The medicine is also prohibited for patients with a history of recurrent peptic ulcers or gastrointestinal haemorrhage, those with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure. Use is also prohibited during the last trimester of pregnancy and for managing peri-operative pain in the setting of CABG surgery.

Age and Restricted Use

Age-related eligibility rules state that Gofen is generally not recommended for children under six years of age or those weighing less than 20 kg. Elderly patients and those with mild to moderate reduction in liver or kidney function are required to use the medicine with particular caution, typically mandating the lowest effective dose for the shortest possible duration. Furthermore, women who are attempting to conceive should be advised that use is not recommended as it may impair female fertility. High doses (ge2400 mg/day) are also restricted for patients with established cardiovascular conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Gofen (Ibuprofen) is structured around documented pharmacokinetic and pharmacodynamic constraints derived from regulatory data.

Prohibited Combinations and Enhanced Risk Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, is formally contraindicated due to a substantially increased risk of serious gastrointestinal adverse events, such as ulceration and bleeding. Regulatory restrictions also apply to its use for managing peri-operative pain after Coronary Artery Bypass Graft (CABG) surgery. A significant pharmacodynamic interaction exists with anticoagulants, antiplatelet agents, and Selective Serotonin Reuptake Inhibitors (SSRIs), which is documented to increase the overall risk of bleeding.

Effect on Co-administered Medicines and Exposure Ibuprofen is documented to reduce the desired therapeutic efficacy of antihypertensives, such as ACE inhibitors and Angiotensin II antagonists, and diuretics. Pharmacokinetic interactions are formally stated for drugs like Lithium and Methotrexate, where Ibuprofen decreases their renal clearance, leading to increased plasma concentrations. Concomitant use with inhibitors of the CYP2C9 enzyme, such as Fluconazole, is documented to increase the systemic exposure of Ibuprofen itself.

Specific Regulatory Requirements Mandatory timing separation rules apply when co-administering with low-dose Aspirin (leq 81 mg), requiring Ibuprofen to be administered at least eight hours before or 30 minutes after the immediate-release form of Aspirin. Alcohol consumption is restricted due to a formally increased risk of gastrointestinal bleeding. Furthermore, the risk of adverse interactions is documented as being heightened in the elderly population.

Mechanism of Action

Enzyme Inhibition and Prostaglandin Synthesis

The primary mechanism involves the non-selective, reversible inhibition of Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By reversibly blocking these enzymes, the drug prevents the conversion of Arachidonic Acid into prostaglandins and related molecular mediators. This action initiates a mechanistic cascade that affects multiple physiological systems by reducing the synthesis of these underlying chemical signals.

Modulation of Peripheral and Central Signaling

The resulting reduction in prostaglandin production leads to two distinct physiological consequences. Peripherally, it dampens the PGE2-driven sensitization of nociceptors (pain receptors), resulting in an altered activation threshold of peripheral nociceptors. Centrally, the mechanism targets the hypothalamus, removing the PGE2 signal that chemically elevates the body’s thermostatic set-point, which permits the activation of heat-dissipating mechanisms once the central thermoregulatory set-point has been reset.

Dosage and Administration Information

Official Administration Principles

Gofen (Ibuprofen) is officially administered primarily via the oral route, available in forms such as tablets, capsules, and oral suspensions. The intravenous route is generally reserved for highly specialized, controlled settings, such as the management of specific conditions in neonatal care.


Dosing Patterns and Frequency

Usage is dictated by the context of treatment. For acute, intermittent relief, the standard single dose for adults is typically 200 mg to 400 mg, which may be administered as needed every 4 to 6 hours. Non-prescription use is officially limited, specifying that the total daily intake should not exceed 1200 mg.

For prescription-based, chronic management (such as certain inflammatory conditions), the maintenance dosing may range from 1200 mg to 3200 mg per day, generally divided into three or four equal doses taken daily to maintain steady systemic concentration. The maximum approved daily dose is 3200 mg.


Administration Context and Duration

Official instructions specify that the medication may be taken with food or milk to help mitigate gastrointestinal discomfort that could interfere with administration. Furthermore, official guidance states that non-prescription use should be constrained to a maximum of 3 to 5 consecutive days for symptomatic relief without further medical review. When using liquid forms, the product must be shaken well immediately prior to using a dedicated device for accurate measurement. Dosage principles require the use of the lowest effective dose for the shortest duration necessary in specific populations, including older adults and individuals with mild hepatic or renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Clinical Trials: Efficacy and Outcomes

Phase 3 Trial Findings Studies have examined whether clinical outcomes are affected in patients with symptoms. The primary aim was to evaluate the impact on disease activity scores over a 12-week period.

The research investigated the drug's influence on a specific signaling pathway. Research also evaluated whether the drug influences key inflammatory markers and disease activity.

Phase 3 trials reported findings regarding the reduction of flare-ups. The studies examined whether the medication was associated with changes in joint pain.


Safety and Tolerability Profile Data on the safety profile was collected during all clinical investigation phases. Studies documented the monitoring of liver function closely.

Adverse event rates were monitored and reported across all treatment arms. The data was analyzed regarding use in individuals who have failed standard therapies.


Studies on Combination Therapy

Combination Use Results Furthermore, studies examined whether the combination of this drug with existing therapies affected patient quality of life compared to monotherapy. This research explored the effect on various patient-reported outcome measures.

Studies identified specific findings for participants with a history of heart conditions.


Comparative Data Comparative safety data was collected against those reported for older drug classes. The research evaluated whether the frequency of hospitalizations was reduced.

Long-term safety data was collected to evaluate chronic use. These studies reported differences between the drug and placebo in key primary endpoints.

Frequently Asked Questions (FAQ)

Common questions about Gofen (FAQ)

Q: Is Gofen available over the counter?

A: Yes, Gofen's active ingredient, Ibuprofen, is recognized by regulatory authorities as a medicine available for Over-the-Counter (OTC) or non-prescription use. This status applies when the medicine is used for the temporary relief of common, self-limiting conditions at specific dose limits.

Q: Is Gofen the same as (Common similar medicine A)?

A: Gofen contains Ibuprofen as its sole active ingredient. Regulatory documents confirm that Ibuprofen is the same compound found in numerous other branded and generic medicines globally, meaning the drug's core active ingredient is the same across these various products.

Q: What happens if I stop taking Gofen suddenly?

A: For short-term, non-prescription use, the adverse effects reported are generally described in regulatory documents as transient and reversible upon cessation of treatment. Official information generally describes effects as transient and reversible upon cessation.

Q: Is it common to feel tired when taking Gofen?

A: Official regulatory documents list fatigue (tiredness) and dizziness among the documented adverse reactions to the medicine. These effects are classified under nervous system effects in the product information.

Q: Can I take Gofen if I am already taking blood pressure medication?

A: Regulatory documents describe that Gofen may reduce the therapeutic efficacy of certain medicines used to treat high blood pressure. This includes classes of medicine such as ACE inhibitors, Angiotensin II antagonists, and diuretics.

Q: Is Gofen safe for older adults (seniors)?

A: Official regulatory notes document an increased risk of specific adverse effects for individuals over 65 years of age. These documented risks include heart failure, gastrointestinal ulceration, and renal impairment.

Q: Are there different strengths or formulations of Gofen?

A: Regulatory standards accommodate multiple strengths of Gofen, including 200 mg and 400 mg tablets. The medicine is also available in various oral forms, such as liquid suspensions in varying concentrations for pediatric use.

Q: Can Gofen be crushed or split?

A: General instructions for taking the tablets or capsules advise swallowing them whole. The instruction to swallow whole is provided to ensure the medicine’s properties are maintained during administration.

Q: What happens if I miss a dose of Gofen?

A: Official patient information advises that if a dose is forgotten, it should be taken when relief is next needed. Official patient information indicates that two doses should not be taken at the same time to compensate for a missed dose.

Q: What is the evidence regarding Gofen and heart health?

A: Regulatory agencies have placed warnings describing an increased risk of serious arterial thrombotic events, such as myocardial infarction and stroke. Regulatory warnings specify that this risk is associated with higher doses and prolonged duration of use.

Q: Are there special considerations for people with kidney disease using Gofen?

A: Official labeling describes that treatment is not generally recommended in patients with advanced renal disease. Caution is advised for use in those with mild to moderate impairment, often requiring the lowest effective dose.

Q: Is Gofen commonly used for muscle aches?

A: Official labeling states that the drug is indicated for the temporary relief of minor aches and pains. This is documented to include the temporary relief of pain associated with muscular aches.

Q: How does Gofen compare generally to other medicines in its class?

A: Research studies have been conducted to compare the efficacy and safety profile of the drug's active ingredient against other medicines within the Nonsteroidal Anti-inflammatory Drug (NSAID) class. This research helps inform regulatory assessments of the medicine.

Q: What research evidence supports the use of Gofen for (one of its approved uses)?

A: Clinical trials have specifically examined the drug’s effect on measurable symptoms of inflammatory conditions. Examples include the reduction of joint pain and the management of flare-ups in conditions like minor pain of arthritis.

Q: Are there gender-specific considerations for Gofen use?

A: Official prescribing information does not recommend sex-specific differentiation in dosing. However, some studies have observed differences in how the body processes the medicine (pharmacokinetics) between men and women of certain age groups.

Q: What is the standard regulatory classification of Gofen?

A: The medicine's active ingredient is recognized as an Over-the-Counter (OTC) drug when used for self-limiting conditions at specific dose limits. Higher dose products are typically reserved for prescription use.

Q: Can Gofen be used for headaches?

A: Yes, official labeling states that the medicine is used for the temporary relief of minor aches and pains associated with headaches.

Q: Is Gofen associated with any specific allergic reactions?

A: Official warnings describe the potential for severe allergic reactions, which are classified as hypersensitivity reactions. Symptoms can include rash, hives, facial swelling, and, in rare cases, shock.

Q: Does Gofen affect sleep?

A: The official adverse reaction profile includes reports of effects on the central nervous system, such as fatigue (tiredness) and dizziness. These are documented effects that may potentially impact alertness or rest.

Q: Are there different brand names for the same Gofen ingredient?

A: Yes, the active ingredient in Gofen is Ibuprofen, which is contained in numerous other branded and generic medicines globally. This is a common practice for established pharmaceutical compounds.

Q: What is the official statement on Gofen and breastfeeding?

A: Data compiled by authoritative bodies indicates that Ibuprofen appears in breast milk in very low concentrations. It is documented as a preferred choice for pain relief in nursing mothers.

Q: Are there any known issues with Gofen and sun sensitivity?

A: Official regulatory documents have documented rare cases of photosensitivity (increased sensitivity to sunlight) as an adverse reaction. This is a potential reaction that users should be aware of.

Q: Does Gofen affect my ability to drive or operate machinery?

A: Official patient information contains warnings that the medicine may cause effects such as dizziness or tiredness. Caution is therefore advised when performing tasks that require alertness, such as driving or operating machinery.

Q: Why do doctors prescribe Gofen?

A: Regulatory documents indicate that healthcare providers may prescribe Gofen at higher daily doses, such as 2400 mg or 3200 mg. This is typically done for the chronic management of specific inflammatory conditions, exceeding the limits for non-prescription use.

Q: How quickly does Gofen usually start working?

A: While the exact time of onset can vary by individual and formulation, some specific products, like soft-gel capsules, are documented as being marketed for potentially quicker absorption compared to standard tablets.

Q: How long does the effect of one Gofen tablet typically last?

A: According to the official dosing pattern for non-prescription use, a dose is typically taken as needed every 4 to 6 hours to maintain relief.

Q: Can Gofen be taken long-term?

A: Non-prescription use is officially constrained to a maximum of 3 to 5 consecutive days. However, prescription-based chronic management for certain inflammatory conditions is documented for periods longer than the non-prescription limit.

Q: What are the official warnings about Gofen and liver problems?

A: Regulatory documents prohibit the use of Gofen in cases of severe hepatic (liver) failure. The official safety information also requires close monitoring of liver function during prescription treatment.

Q: Can children or teenagers use Gofen?

A: Regulatory rules state that the medicine is generally not recommended for children under six years of age. Specific weight-based dosing schedules, however, are published for children aged 3 months to 12 years.

Q: Is Gofen approved for use during pregnancy?

A: The medicine is contraindicated (prohibited) during the last trimester of pregnancy. For the first six months, use is not recommended unless potential benefits are described as clearly outweighing the possible risk to the fetus.

Q: Can Gofen be taken with food, or does it matter?

A: Official instructions specify that the medicine may be taken with food or milk. This administration context is described as a measure to help manage potential gastrointestinal discomfort.

Q: What is the general recommended period for using Gofen?

A: The officially recommended duration is constrained to a maximum of 3 to 5 consecutive days for non-prescription symptomatic relief. Longer-term use is reserved exclusively for prescription-based chronic management.

Q: Does Gofen interact with alcohol?

A: Alcohol consumption is formally restricted because of a documented and increased risk of gastrointestinal bleeding when used in combination with the medicine.

Q: What are the potential drug-drug interactions with Gofen?

A: Documented interactions primarily involve other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), medicines that affect blood clotting (e.g., anticoagulants), and certain medicines used to treat high blood pressure and mental health conditions (SSRIs).

Q: Why does the packaging say 'Talk to your doctor if...' for certain conditions?

A: Official documents establish two categories of restriction: absolute contraindications (prohibited use) and conditions requiring caution (restricted use). Conditions under caution mandate that the lowest effective dose and shortest duration be used, necessitating medical consultation.

How should Gofen be stored and disposed of?

Official Storage and Disposal Requirements for Gofen

Regulatory labeling dictates specific conditions necessary to maintain the quality and integrity of Gofen (Ibuprofen Soft Capsules) over its documented shelf life.

Storage Constraints

Requirement Official Statement
Temperature Store below 25 C or 30 C, depending on the specific product formulation.
Protection Keep in the original container to protect the medicine from moisture and away from direct sunlight.
Child Safety Mandatory requirement to keep the medicine out of the sight and reach of children.

Disposal Instructions

Any unused or expired Gofen product must be handled in accordance with local requirements for pharmaceutical waste. The official instruction is to avoid disposal via wastewater. Consumers are directed to utilize authorized medicine take-back programs or follow secure household trash guidelines for non-flushable medications.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gofen found in:

A-Z Index: